Patent ID: 8404235

Claim:
A method of improving survivability or quality of life of a patient in need thereof having elevated C-reactive protein levels, comprising administering to the patient an anti-IL-6 antibody or antibody fragment, wherein the variable light chain of said antibody comprises the CDR 1 sequence of SEQ ID NO: 4, the CDR 2 sequence of SEQ ID NO: 5, and the CDR 3 sequence of SEQ ID NO: 6, and the variable heavy chain of said antibody comprises the CDR 1 sequence of SEQ ID NO: 7, the CDR 2 sequence of SEQ ID NO: 8 or 120, and the CDR 3 sequence of SEQ ID NO: 9, and whereby the patient's serum C-reactive protein (“CRP”) is reduced, and whereby the administration of the anti-IL-6 antibody or antibody fragment results in improved survivability or quality of life in said patient.